Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, a significant proportion of the MDS population will be left underserved by pharmacotherapy.
Published By Datamonitor
|
18 Oct 2005 |
$1900
|
Report
|
An overview of risk-sharing agreements and their utilization in the UK, US, Italy and Australia. The pros and cons of risk-sharing agreements are discussed and key strategic recommendations, supported by in depth case study analysis.
Published By Datamonitor
|
16 Jul 2009 |
$3800
|
Order this report by October 22nd 2010 and receive a 50% discount
To take advantage of this offer enter Promo Code Orphan50 when prompted in the checkout
More information
|
Report
|
Overview of orphan drug strategies in the seven major markets, providing insight into developmental and commercial drivers and resistors, and Pharma's growing focus on targeting niche indications as the primary care blockbuster era nears its end.
Published By Datamonitor
|
02 Oct 2009 |
$3800
|
Report
|
Diversification is one strategy Big Pharma is using to contend with the oncoming patent cliff, however, Datamonitor has analyzed ten sectors within healthcare and concluded that remaining pharma-focused will lead to maximum revenue growth.
Published By Datamonitor
|
12 Nov 2009 |
$7600
|
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Report
|
Assess the outlook for the PharmaVitae universe of leading Rx pharma companies to 2014, in terms of both sales and operating performance. Analyze the industry by peer set, balance of launches / expiries, and therapeutic and molecule type focus.
Published By Datamonitor
|
23 Dec 2009 |
$7600
|
Report
|
An overview of key trends shaping the pharmaceutical industry today, as well as drivers and resistors that are set to play a central role in the future as companies look to increase sales and boost profitability.
Published By Datamonitor
|
17 Mar 2010 |
$11400
|
Report
|
A comprehensive overview of licensing deals and strategies employed by the top 10 pharma companies during 2008-09, with intertwined case study analysis and an assessment of evolving trends observed in the global pharmaceutical licensing landscape.
Published By Datamonitor
|
24 Mar 2010 |
$15200
|
Report
|
This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.
Published By Datamonitor
|
25 May 2010 |
$3800
|
Report
|
Overview of the Australian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
29 Jul 2010 |
$7600
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.